Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Listed
Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 847 across all filing types
Latest filing 2026-06-19 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BXN · 3 venues

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BXN 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and concerns the application for quotation of new securities resulting from options exercised or convertible securities converted by BIOXYNE LIMITED. The content involves the issuance and listing of additional securities and complies with ASX listing rules. It does not contain financial results, management discussion, or report-type content. The specifics of securities issuance classify it under announcements related to capital changes or share issue. According to the definitions and the content, this document is a Share Issue/Capital Change announcement.
2026-06-19 English
Results of Meeting 2 pages 386.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX (Australian Securities Exchange) announcement dated 19 June 2026, titled 'RESULTS OF GENERAL MEETING'. It provides detailed proxy and poll voting results for resolutions passed at a general meeting. Specific resolutions include change of company name and consolidation of capital. The content focuses exclusively on the official voting results of a shareholder meeting rather than the meeting materials (AGM presentations) or notices. The document length is short (~1774 characters) and the text does not contain any financial statements or detailed analysis. Given the description, this document clearly reports the official results from shareholder votes at a general meeting, matching the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2026-06-19 English
Bioxyne General Meeting 19.6.2026 1 page 313.7KB
Regulatory Filings Classification · 85% confidence The document is an announcement regarding a General Meeting with details on date, time, location, and agenda items including a company name change and capital consolidation. It does not contain full financial statements or detailed reports, nor does it indicate voting results or management changes post-meeting. It is not the notice itself as that was lodged previously (as per mention of 21 May 2026 notice), so this is a meeting reminder/announcement. Given that it is about resolutions to be considered at a general meeting, and no other detailed financial or governance report is included, the classification fits best with a Regulatory Filings (RNS) since it is a general regulatory announcement and does not belong to the more specific categories like AGM-R, DVA, or SHA which require different types of content.
2026-06-18 English
Initial Director's Interest Notice 2 pages 190.5KB
Director's Dealing Classification · 91% confidence The document is an ASX Appendix 3X “Initial Director’s Interest Notice” disclosing a director’s securities interests under listing rule 3.19A.1. This is a personal interest disclosure by a company director (insider reporting). This aligns with the “Director's Dealing” category (Code: DIRS).
2026-06-05 English
New Independent Director to Strengthen Board 3 pages 368.9KB
Board/Management Information Classification · 90% confidence The document is a press release announcing the appointment of Edward Myer as an independent Non-Executive Director and committee chair, clearly detailing a change in board composition. This fits the Board/Management Information category, which covers announcements of board or senior management changes.
2026-06-03 English
Investor Presentation - Coffee Microcaps Webinar 25 pages 1.8MB
Investor Presentation Classification · 93% confidence The document is a slide-based investor presentation, complete with forward-looking disclaimers, corporate overview, financial guidance, and strategic highlights. It clearly serves as an Investor Presentation (detailed slides for investors), not merely an announcement or earnings release. Therefore it falls under the Investor Presentation category (IP).
2026-06-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.